Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis

The Lancet Neurology

Volumn 14, Issue 3, 2015, Pages 253-262

  Rohrer, Jonathan D ^a   Nicholas, Jennifer M ^a,c   Cash, David M ^a   van Swieten, John ^d   Dopper, Elise ^d   Jiskoot, Lize ^d   van Minkelen, Rick ^d   Rombouts, Serge A ^e   Cardoso, M Jorge ^a   Clegg, Shona ^a   Espak, Miklos ^a   Mead, Simon ^a   Thomas, David L ^a   De Vita, Enrico ^a,b   Masellis, Mario ^f   Black, Sandra E ^f   Freedman, Morris ^g,i   Keren, Ron ^j   MacIntosh, Bradley J ^f   Rogaeva, Ekaterina ^h   Tang Wai, David ^j   Tartaglia, Maria Carmela ^h   Laforce, Robert ^k   Tagliavini, Fabrizio ^l   Tiraboschi, Pietro ^l   Redaelli, Veronica ^l   Prioni, Sara ^l   Grisoli, Marina ^l   Borroni, Barbara ^m   Padovani, Alessandro ^m   Galimberti, Daniela ⁿ   Scarpini, Elio ⁿ   Arighi, Andrea ⁿ   Fumagalli, Giorgio ⁿ   Rowe, James B ^o   Coyle Gilchrist, Ian ^o   Graff, Caroline ^p,q   Fallström, Marie ^q   Jelic, Vesna ^p,q   Ståhlbom, Anne Kinhult ^a,p   Andersson, Christin ^p,q   Thonberg, Håkan ^p,q   Lilius, Lena ^p   Frisoni, Giovanni B ^r,s   Pievani, Michela ^r   Bocchetta, Martina ^m,r   Benussi, Luisa ^r   Ghidoni, Roberta ^r   Finger, Elizabeth ^t   Sorbi, Sandro ^u   Nacmias, Benedetta ^u   Lombardi, Gemma ^u   Polito, Cristina ^u   Warren, Jason D ^a   Ourselin, Sebastien ^a   Fox, Nick C ^a   Rossor, Martin N ^a   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY   (Netherlands)

^f UNIVERSITY OF TORONTO   (Canada)

^g MOUNT SINAI HOSPITAL   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ ROTMAN RESEARCH INSTITUTE   (Canada)

^j TORONTO WESTERN HOSPITAL   (Canada)

^k LAVAL UNIVERSITY   (Canada)

^l DEPARTMENT OF NEUROSURGERY   (Italy)

^m UNIVERSITY OF BRESCIA   (Italy)

ⁿ UNIVERSITY OF MILAN   (Italy)

^o UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^p KAROLINSKA INSTITUTE   (Sweden)

^q KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^r Istituto Centro San Giovanni di Dio Fatebenefratelli   (Italy)

^s UNIVERSITY OF GENEVA   (Switzerland)

^t UNIVERSITY OF WESTERN ONTARIO   (Canada)

^u UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME 9 OPEN READING FRAME 72; PEPTIDES AND PROTEINS; PROGRANULIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANADA; CLINICAL ASSESSMENT; COGNITION; CROSS-SECTIONAL STUDY; EXECUTIVE FUNCTION; FEMALE; FIRST DEGREE RELATIVE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HETEROZYGOTE; HUMAN; INSULA; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NETHERLANDS; NEUROANATOMY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; RECALL; SWEDEN; TEMPORAL LOBE; UNITED KINGDOM; ASYMPTOMATIC DISEASE; BRAIN; CLINICAL TRIAL; COGNITION DISORDERS; GENETICS; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGY;

ADULT; ASYMPTOMATIC DISEASES; BRAIN; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TESTS;

EID: 84923267269     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70324-2     Document Type: Article

References (51)

1. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 2011, 82:476-486.
2. Onyike CU, Diehl-Schmid J The epidemiology of frontotemporal dementia. Int Rev Psychiatry 2013, 25:130-137.
3. Rohrer JD, Guerreiro R, Vandrovcova J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009, 73:1451-1456.
4. Warren JD, Rohrer JD, Rossor MN Clinical review. Frontotemporal dementia. BMJ 2013, 347:f4827.
5. Rohrer JD, Warren JD, Fox NC, Rossor MN Presymptomatic studies in genetic frontotemporal dementia. Rev Neurol (Paris) 2013, 169:820-824.
6. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 2002, 99:4703-4707.
7. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009, 8:791-801.
8. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012, 367:795-804.
9. Janssen JC, Schott JM, Cipolotti L, et al. Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2005, 76:162-168.
10. Rohrer JD, Beck J, Plagnol V, et al. Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia. J Neurol Neurosurg Psychiatry 2013, 84:1411-1412.
11. Rohrer JD, Warren JD, Barnes J, et al. Mapping the progression of progranulin-associated frontotemporal lobar degeneration. Nat Clin Pract Neurol 2008, 4:455-460.
12. Cruchaga C, Fernández-Seara MA, Seijo-Martínez M, et al. Cortical atrophy and language network reorganization associated with a novel progranulin mutation. Cereb Cortex 2009, 19:1751-1760.
13. Pievani M, Paternicò D, Benussi L, et al. Pattern of structural and functional brain abnormalities in asymptomatic granulin mutation carriers. Alzheimers Dement 2014, 10(5 suppl):S354-63.e1.
14. Jacova C, Hsiung GY, Tawankanjanachot I, et al. Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers. Neurology 2013, 81:1322-1331.
15. Hallam BJ, Jacova C, Hsiung GY, et al. Early neuropsychological characteristics of progranulin mutation carriers. J Int Neuropsychol Soc 2014, 20:694-703.
16. Ferman TJ, McRae CA, Arvanitakis Z, Tsuboi Y, Vo A, Wszolek ZK Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation. Parkinsonism Relat Disord 2003, 9:265-270.
17. Spina S, Farlow MR, Unverzagt FW, et al. The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Brain 2008, 131(Pt 1):72-89.
18. Miyoshi M, Shinotoh H, Wszolek ZK, et al. In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: a PET and MRI study. Parkinsonism Relat Disord 2010, 16:404-408.
19. Borroni B, Alberici A, Premi E, et al. Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. Rejuvenation Res 2008, 11:585-595.
20. Whitwell JL, Josephs KA, Avula R, et al. Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD. Neurology 2011, 77:866-874.
21. Borroni B, Alberici A, Cercignani M, et al. Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. Neurobiol Aging 2012, 33:2506-2520.
22. Dopper EG, Rombouts SA, Jiskoot LC, et al. Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia. Neurology 2013, 80:814-823.
23. Premi E, Gazzina S, Bozzali M, et al. Cognitive reserve in granulin-related frontotemporal dementia: from preclinical to clinical stages. PLoS One 2013, 8:e74762.
24. Premi E, Cauda F, Gasparotti R, et al. Multimodal FMRI resting-state functional connectivity in granulin mutations: the case of fronto-parietal dementia. PLoS One 2014, 9:e106500.
25. Premi E, Formenti A, Gazzina S, et al. Effect of TMEM106B polymorphism on functional network connectivity in asymptomatic GRN mutation carriers. JAMA Neurol 2014, 71:216-221.
26. Kantarci K, Boeve BF, Wszolek ZK, et al. MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology. Neurology 2010, 75:771-778.
27. Mioshi E, Hsieh S, Savage S, Hornberger M, Hodges JR Clinical staging and disease progression in frontotemporal dementia. Neurology 2010, 74:1591-1597.
28. Wear HJ, Wedderburn CJ, Mioshi E, et al. The Cambridge Behavioural Inventory revised. Dementia Neuropsychologia 2008, 2:102-107.
29. Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006, 20:210-216.
30. Jorge Cardoso M, Leung K, Modat M, et al. STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation. Med Image Anal 2013, 17:671-684.
31. Cortical parcellation (anatomical labeling) protocol brainCOLOR, (accessed Nov 14, 2013). http://www.braincolor.org/protocols/docs/BrainCOLOR_cortical_parcellation_protocol.pdf.
32. Segmentation Protocols Neuromorphometrics, Inc, (accessed Nov 14, 2013). http://www.neuromorphometrics.org:8080/seg.
33. Cardoso MJ, Wolz R, Modat M, Fox NC, Rueckert D, Ourselin S Geodesic information flows. Med Image Comput Comput Assist Interv 2012, 15(Pt 2):262-270.
34. Diedrichsen J, Balsters JH, Flavell J, Cussans E, Ramnani N A probabilistic MR atlas of the human cerebellum. Neuroimage 2009, 46:39-46.
35. Freeborough PA, Fox NC, Kitney RI Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 1997, 53:15-25.
36. Ryman DC, Acosta-Baena N, Aisen PS, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 2014, 83:253-260.
37. Laird NM, Ware JH Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
38. Sullivan LM, Dukes KA, Losina E An introduction to hierarchical linear modelling. Stat Med 1999, 18:855-888.
39. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011, 134(Pt 9):2456-2477.
40. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology 2011, 76:1006-1014.
41. Seeley WW, Menon V, Schatzberg AF, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 2007, 27:2349-2356.
42. Zhou J, Greicius MD, Gennatas ED, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 2010, 133(Pt 5):1352-1367.
43. Whitwell JL, Weigand SD, Boeve BF, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 2012, 135(Pt 3):794-806.
44. Mahoney CJ, Beck J, Rohrer JD, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012, 135(Pt 3):736-750.
45. Warren JD, Rohrer JD, Schott JM, Fox NC, Hardy J, Rossor MN Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends Neurosci 2013, 36:561-569.
46. Rohrer JD, Ridgway GR, Modat M, et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage 2010, 53:1070-1076.
47. Premi E, Garibotto V, Gazzina S, et al. Subcortical and deep cortical atrophy in frontotemporal dementia due to granulin mutations. Dement Geriatr Cogn Dis Extra 2014, 4:95-102.
48. Khan BK, Yokoyama JS, Takada LT, et al. Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry 2012, 83:358-364.
49. Suhonen NM, Kaivorinne AL, Moilanen V, et al. Slowly progressive frontotemporal lobar degeneration caused by the C9ORF72 repeat expansion: a 20-year follow-up study. Neurocase 2015, 21:85-89.
50. Gómez-Tortosa E, Serrano S, de Toledo M, Pérez-Pérez J, Sainz MJ Familial benign frontotemporal deterioration with C9ORF72 hexanucleotide expansion. Alzheimers Dement 2014, 10(5 suppl):S284-S289.
51. Villemagne VL, Okamura N In vivo tau imaging: obstacles and progress. Alzheimers Dement 2014, 10(3 suppl):S254-S264.